{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-269502","form_type":"8-K","ticker":null,"cik":"0001538210","company_name":"NexImmune, Inc.","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.424640+00:00","generated_at":"2026-06-09T00:10:46.030739+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"NexImmune board approves dissolution plan and reduction-in-force of substantially all employees","bullets":["Board unanimously approved liquidation and dissolution, subject to stockholder approval, on November 2, 2023.","Reduction-in-force of substantially all employees approved October 31, 2023; only key management retained for wind-down.","Company will call a special stockholder meeting to vote on dissolution; proxy materials to be filed.","Reduction-in-force expected to be substantially complete in November 2023; cost estimate not yet determinable."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-269502","json":"https://secwatch.observer/filing/0001193125-23-269502.json","markdown":"https://secwatch.observer/filing/0001193125-23-269502.md","text":"https://secwatch.observer/filing/0001193125-23-269502.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1538210/000119312523269502/0001193125-23-269502-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1538210/000119312523269502/d376920d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T00:10:46.030739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b37b7ee7a6b4bdfb2bab9c38b84bbcf4242c27bc","claim":"NexImmune, Inc. announced a restructuring affecting the Company (liquidation and wind up) (substantially all of the Company’s employees).","evidence_excerpt":"On October 31, 2023, the Board also approved a reduction-in-force of substantially all of the Company’s employees, other than key members of management necessary to implement the wind up and support the efforts to maximize the value of the business and its assets.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1538210/000119312523269502/0001193125-23-269502-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Affected area","value":"the Company (liquidation and wind up)"},{"label":"Headcount","value":"substantially all of the Company’s employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}